Our name is Gladskin
for a reason.
Who is Gladskin?
Glad you asked.
Gladskin was born from a discovery about the role of endolysin proteins in maintaining a balanced and healthy skin microbiome. This breakthrough was made by Professor Dr. Martin Loessner’s Department of Health Sciences and Technology Laboratory at the ETH Zurich University in Switzerland.
Our science is founded on the belief that we must respect Mother Nature's complexity when solving health issues. We believe in truly restoring health, rather than simply reducing symptoms (although we do that too).
We respect the fact that human bodies evolved naturally over billions of years. We believe that because of new microbiome science, we are on the brink of a scientific revolution that is redefining health.
We'd like to thank our advisors and researchers from Yale University, University of Chicago, University of Seattle, The National Eczema Association, the Public Health Laboratory in the Netherlands, and the Erasmus Medical Center. With these top doctors and scientists, we are leading the way—creating practical, easily available products that safely solve inflammatory skin health problems, including eczema.
ETH Zurich Campus, Micreobalance™ birthplace
The Gladskin Lab in the Netherlands
The international Gladskin team at an offsite
Our mission is simple: to make skin glad for everyone by working with the nature of skin itself to restore skin health. We care about people and are driven to relieve human health struggles in ways that help, don’t harm.
Nature is smart. The smartest scientists work with and respect its subtle powers. We believe Gladskin products should work fast and have no known adverse effects. We strive to make them sustainable and affordable so people everywhere can live with glad skin.
Gladskin is a new solution that works differently than steroids and traditional drugstore OTC products. These products don’t rebalance the skin microbiome imbalance. Worse yet, they contain preservatives, which kill both the good and the bad bacteria. Without good bacteria, your skin microbiome is weaker and more vulnerable.
Our Product Offering
Not a stronger product.
It's a smarter solution.
Our Scientific Advisory Board
Peter Lio, MD
Assistant Clinical Professor of Dermatology & Pediatrics, Northwestern University School of Medicine
National Eczema Association Scientific Advisory Board Member
Richard Antaya, MD
Professor of Dermatology, Yale School of Medicine
Director, Pediatric Dermatology, Yale Dermatology Associates
Robert Sidbury, MD
Professor, Department of Pediatrics University of Washington School of Medicine
Chief, Division of Dermatology, Seattle Children's Hospital